Could a common amino acid prove to be a potential therapeutic agent for the reduction of arthritis and bone loss?
Rheumatoid arthritis (RA) affects millions of people worldwide, causing joint pain and bone loss due to the excessive activity of bone-resorbing cells, known as osteoclasts. The latest research findings indicate that L-arginine, a common amino acid, may play a pivotal role in the inhibition of this destructive process. It was discovered that L-arginine has the capacity to „reprogram“ osteoclasts, effecting a transition in their energy production from a process that is conducive to bone loss to one that is inhibitory. By modifying the cells‘ metabolism, L-arginine effectively reduces osteoclast formation and activity, resulting in reduced bone erosion. This discovery provides a potential avenue for developing new treatments for RA that utilise the properties of this amino acid to protect our bones. Could L-arginine supplements become a simple and effective strategy to combat arthritis and preserve bone health? Our findings suggest that this is a possibility that warrants further investigation.
Read more here ⬇
https://doi.org/10.1136/ard-2022-223626
Wrapping up an Incredible TRR369 DIONE Student Training Week! 🎉
What an amazing week in Erlangen it’s been! 💡 From insightful lectures to hands-on training, the participants dove deep into cutting-edge osteoimmunology and inflammation models, building their knowledge and skills. 🔬🤩 The combination of learning, networking, and exchanging ideas across disciplines made this a truly special experience.
We capped it all off with a fantastic farewell dinner 🍽️, but this is just the beginning. Excitement is already building for the next DIONE Workshop, set to take place in Dresden in 2025! 📅
Big things are on the horizon—stay tuned for more updates from this dynamic research community!
Some impressions of the workshop
Start of the 1st DIONE Trainingsweek
We’re thrilled to announce the kickoff of the #TRR369 #DIONE Student Training Week focused on #inflammation models! 🧬
Young scientists are coming together to deepen their knowledge and skills in cutting-edge osteoimmunology research. 🧑🔬👩🔬
With a focus on understanding the complex link between inflammation and #bone #health, this week is all about hands-on learning, human inflammatory diseases and collaboration across disciplines. 🌍🔬
Stay tuned for updates and breakthroughs from these rising stars in research! ✨💡
DIONE is Here: Unlocking the Future of Bone Health!
Have you ever wondered how inflammation affects more than just swelling or pain? Introducing DIONE—a groundbreaking research consortium that’s changing how we understand the connection between inflammation and bone health.
What is DIONE?
DIONE, or Transregio (TRR) 369, is a cutting-edge research network funded by the German Research Foundation (Deutsche Forschungsgemeinschaft (DFG) – German Research Foundation). With a team of 30 top scientists spread across 19 subprojects, DIONE brings together expertise from key research hubs at FAU Erlangen-Nürnberg, Technische Universität Dresden, Leibniz-Institut für Analytische Wissenschaften – ISAS – e.V., and Universität Ulm. Together, they are pushing the boundaries of scientific discovery.
So, what does DIONE do?
DIONE’s mission is to explore how inflammation affects bone health, particularly through a field known as osteoimmunology. By studying how the immune system and bone tissue interact, the team aims to uncover the hidden mechanisms that link inflammation to conditions like osteoporosis.
When inflammation strikes, it doesn’t just cause pain—it prompts immune cells to release powerful signals like cytokines. These signals disrupt the delicate balance between cells that build bone (osteoblasts) and those that break it down (osteoclasts). Over time, this can lead to serious conditions like bone loss and fractures, particularly in people with chronic inflammatory diseases like rheumatoid arthritis, periodontitis, and psoriatic arthritis.
Why does DIONE matter?
Osteoporosis is already a global health challenge, affecting over 200 million people worldwide. But what if inflammation is a bigger part of the story than we thought? DIONE is here to fill that knowledge gap by identifying the molecular pathways that drive bone loss in inflammatory diseases.
By collaborating across disciplines—biology, clinical research, and bioinformatics—DIONE is paving the way for new, innovative treatments that could dramatically improve the quality of life for patients dealing with inflammation-driven bone damage.
Join Us on This Journey!
DIONE isn’t just about research—it’s about reshaping the future of bone health. Stay tuned as we dive deeper into the science behind inflammation and bone degeneration, and follow us for updates on how we’re working to make a difference in millions of lives.
TRR369 DIONE Retreat 2024
We are thrilled to share highlights from the first retreat of our consortium, TRR369 DIONE DFG! On June 17th and 18th, our incredible team of researchers gathered to discuss groundbreaking advancements and the future of our research.
Key Highlights:
-
- Engaging presentations on cutting-edge research.
- Collaborative sessions fostering innovation
- Visionary discussions on the future of our field.
This retreat not only strengthened our collective vision but also reinforced our commitment to driving impactful research and innovation to fight against inflammatory bone loss. We are excited about the journey ahead and the transformative potential of our work.
A huge thank you to all participants for their invaluable contributions and enthusiasm.
Stay tuned for more updates and breakthroughs from TRR369 DIONE! 🚀
Ipsum
viverra quis, feugiat a, tellus. Phasellus viverra nulla ut metus varius laoreet. Quisque rutrum. Aenean imperdiet. Etiam ultricies nisi vel augue. Curabitur ullamcorper ultricies nisi. Nam eget dui. Etiam rhoncus. Maecenas tempus, tellus eget condimentum rhoncus, sem quam semper libero, sit amet adipiscing sem neque sed ipsum. Nam quam nunc, blandit vel, luctus pulvinar, hendrerit id, lorem. Maecenas nec odio et ante tincidunt tempus. Donec vitae sapien ut libero venenatis faucibus. Nullam quis ante. Etiam sit amet orci eget eros faucibus tincidunt. Duis leo. Sed fringilla mauris sit amet nibh. Donec sodales sagittis magna. Sed consequat, leo eget bibendum sodales, augue velit cursus nunc,
Lorem ipsum dolor sit amet, consectetuer adipiscing elit. Aenean commodo ligula eget dolor. Aenean massa. Cum sociis natoque penatibus et magnis dis parturient montes, nascetur ridiculus mus. Donec quam felis, ultricies nec, pellentesque eu, pretium quis, sem. Nulla consequat massa quis enim. Donec pede justo, fringilla vel, aliquet nec, vulputate eget, arcu. In enim justo, rhoncus ut, imperdiet a, venenatis vitae, justo. Nullam dictum felis eu pede mollis pretium. Integer tincidunt. Cras dapibus. Vivamus elementum semper nisi. Aenean vulputate eleifend tellus. Aenean leo ligula, porttitor eu, consequat vitae, eleifend ac, enim. Aliquam lorem ante, dapibus in,
Lorem
Lorem ipsum dolor sit amet, consectetuer adipiscing elit. Aenean commodo ligula eget dolor. Aenean massa. Cum sociis natoque penatibus et magnis dis parturient montes, nascetur ridiculus mus. Donec quam felis, ultricies nec, pellentesque eu, pretium quis, sem. Nulla consequat massa quis enim. Donec pede justo, fringilla vel, aliquet nec, vulputate eget, arcu. In enim justo, rhoncus ut, imperdiet a, venenatis vitae, justo. Nullam dictum felis eu pede mollis pretium. Integer tincidunt. Cras dapibus. Vivamus elementum semper nisi. Aenean vulputate eleifend tellus. Aenean leo ligula, porttitor eu, consequat vitae, eleifend ac, enim. Aliquam lorem ante, dapibus in, viverra quis, feugiat a, tellus. Phasellus viverra nulla ut metus varius laoreet. Quisque rutrum. Aenean imperdiet. Etiam ultricies nisi vel augue. Curabitur ullamcorper ultricies nisi. Nam eget dui. Etiam rhoncus. Maecenas tempus, tellus eget condimentum rhoncus, sem quam semper libero, sit amet adipiscing sem neque sed ipsum. Nam quam nunc, blandit vel, luctus pulvinar, hendrerit id, lorem. Maecenas nec odio et ante tincidunt tempus. Donec vitae sapien ut libero venenatis faucibus. Nullam quis ante. Etiam sit amet orci eget eros faucibus tincidunt. Duis leo. Sed fringilla mauris sit amet nibh. Donec sodales sagittis magna. Sed consequat, leo eget bibendum sodales, augue velit cursus nunc,
Überschrift der News oder des Events
Picient aut officiis doluptur? Exeritio endus et evere lam ipsume as et officitat. Que nis des eosam, aut inumqua ssitat magnatiae pra, inciis aut ommoluptas. Picient aut officiis doluptur? Exeritio endus et evere lam ipsume as et officitat. Que nis des eosam, aut inumqua ssitat magnatiae pra, inciis aut ommoluptas. Picient aut officiis doluptur? Exeritio endus et evere lam ipsume as et officitat. Que nis des eosam, aut inumqua ssitat magnatiae pra, inciis aut ommoluptas.
Picient aut officiis doluptur? Exeritio endus et evere lam ipsume as et officitat. Que nis des eosam, aut inumqua ssitat magnatiae pra, inciis aut ommoluptas. Picient aut officiis doluptur? Exeritio endus et evere lam ipsume as et officitat. Que nis des eosam, aut inumqua ssitat magnatiae pra, inciis aut ommoluptas
Hallo Welt!
Willkommen bei WordPress. Dies ist Ihr erster Beitrag. Bearbeiten oder löschen Sie ihn und beginnen Sie mit dem Schreiben!
